Lanxess (LXS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Sales increased 6.5% year-over-year in Q2 2026 to €1,561 million, driven by higher volumes and prices, with sequential EBITDA pre exceptionals up 61.7% to €152 million and strong free cash flow generation.
Operational performance strengthened by improvements in both pricing and volume, marking Q2 2026 as a turning point, though net income remained negative at minus €53 million.
Structural cost adjustments and restructuring are underway, particularly in Saltigo, to align capacity with future demand and reduce exposure to agrochemicals, targeting €20 million annual savings from 2028.
Adjusted EPS was €0.51 in Q2, down from €0.59, and €0.01 for H1, down from €0.82.
Free cash flow improved to €56 million in Q2 2026 from €31 million in Q2 2025.
Financial highlights
Q2 2026 EBITDA pre exceptionals rose to €152 million, up 62% sequentially, with a margin of 9.7%; sales increased 6.5% year-over-year to €1,561 million.
Net income for Q2 was -€53 million, down from -€45 million in Q2 2025.
Free cash flow turned positive at €27 million in H1, compared to minus €80 million in the prior year.
Net financial liabilities were €2,049 million at June 30, 2026, nearly stable versus year-end.
EUR 500 million bond issued with a 5-year tenor and 4.375% coupon, replacing an October maturity; order book was several times oversubscribed.
Outlook and guidance
Full-year 2026 EBITDA pre exceptionals guidance confirmed at €450–550 million, with Q3 expected at €130–150 million.
No expectation of further economic momentum in core markets for the remainder of 2026; construction sector recovery expected in 2027.
Cost-reduction programs expected to contribute more in the second half of the year.
No significant de-stocking expected in Q3; order book and demand momentum remain steady.
Cost and efficiency programs are expected to yield sustainable savings.
Latest events from Lanxess
- Q2 2026 saw strong sales and EBITDA growth, positive cash flow, and guidance reaffirmed.LXS
Q2 2026 (Media) - Sales and earnings fell, but debt reduction, restructuring, and sustainability drive resilience.LXS
AGM 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained amid persistent market headwinds.LXS
Q1 2026 (Media) - Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 2026 - Sales and EBITDA fell, debt reduced, and EUR 100M cost savings with 550 job cuts announced.LXS
Q4 2025 (Media) - 2026 EBITDA guidance is €450–550 million, with recovery expected in H2 2026.LXS
Q4 2025 - Sales and EBITDA fell sharply in Q3 2025, with cost actions and divestments improving leverage.LXS
Q3 2025 - Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 2025 - EBITDA pre rose 32% to €133m, guidance held, and Urethane sale proceeds to reduce debt.LXS
Q1 2025